Review
Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy
Affiliations
- PMID: 18183537
Item in Clipboard
Review
Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy
Curr Opin Investig Drugs.
2008 Jan.
Abstract
UCB SA was developing the high-affinity synaptic vesicle glycoprotein 2A ligand, seletracetam, an analog of levetiracetam, for the potential oral treatment of epilepsy. Phase II epilepsy trials were underway, but in July 2007, the company stated that development of seletracetam had been put on hold and it is unknown whether planned phase IIb/III trials will begin.
Similar articles
-
Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy.Eur J Pharmacol. 2009 Jul 1;614(1-3):30-7. doi: 10.1016/j.ejphar.2009.04.024. Epub 2009 Apr 19. Eur J Pharmacol. 2009. PMID: 19383493
-
Brivaracetam UCB.Curr Opin Investig Drugs. 2005 Jul;6(7):740-6. Curr Opin Investig Drugs. 2005. PMID: 16044671 Review.
-
Brivaracetam: First Global Approval.Drugs. 2016 Mar;76(4):517-22. doi: 10.1007/s40265-016-0555-6. Drugs. 2016. PMID: 26899665 Review.
-
Seletracetam (UCB 44212).Neurotherapeutics. 2007 Jan;4(1):117-22. doi: 10.1016/j.nurt.2006.11.014. Neurotherapeutics. 2007. PMID: 17199025 Free PMC article. Review.
-
Brivaracetam for the treatment of epilepsy.Expert Opin Pharmacother. 2016;17(2):283-95. doi: 10.1517/14656566.2016.1135129. Epub 2016 Jan 13. Expert Opin Pharmacother. 2016. PMID: 26760311 Review.
Cited by
-
Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial.J Neural Transm (Vienna). 2010 Nov;117(11):1279-86. doi: 10.1007/s00702-010-0472-x. Epub 2010 Aug 29. J Neural Transm (Vienna). 2010. PMID: 20803300 Clinical Trial.
-
Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil.Neurosci Bull. 2024 May;40(5):594-608. doi: 10.1007/s12264-023-01138-2. Epub 2023 Oct 28. Neurosci Bull. 2024. PMID: 37897555 Free PMC article. Review.
-
Levetiracetam Mechanisms of Action: From Molecules to Systems.Pharmaceuticals (Basel). 2022 Apr 13;15(4):475. doi: 10.3390/ph15040475. Pharmaceuticals (Basel). 2022. PMID: 35455472 Free PMC article. Review.
-
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.Drugs. 2010 Feb 12;70(3):287-312. doi: 10.2165/11319230-000000000-00000. Drugs. 2010. PMID: 20166767 Review.
-
Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.Sci Rep. 2016 Jun 6;6:27420. doi: 10.1038/srep27420. Sci Rep. 2016. PMID: 27265781 Free PMC article.